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to the Editor: Studies of ST-segment elevation myocardial infarc-
ion (STEMI) have described unequal distribution of culprit
esions, with the majority occurring in the left anterior descending
rtery (LAD) and right coronary artery (RCA) (1,2). However,
mong patients with non–ST-segment elevation myocardial in-
arction (NSTEMI), there appears to be more uniform distribu-
ion (3,4). One potential explanation is that occluded vessels that
erfuse the anterior or inferior walls are more likely to be
iagnosed as STEMI on the standard 12-lead electrocardiogram
han those vessels that perfuse the posterolateral wall (5).
We analyzed the American College of Cardiology National
ardiovascular Data Registry (ACC-NCDR) database, a national
egistry of diagnostic cardiac catheterization and percutaneous
oronary intervention (PCI) procedures: 1) to describe the ana-
omic distribution and patency of culprit lesions; and 2) to evaluate
linical outcomes in a large cohort of patients with NSTEMI
ndergoing PCI.
From January 2004 to March 2006, data from 47,454 consec-
tive patients undergoing PCI for the indication of NSTEMI were
ntered into the ACC-NCDR database. A total of 16,301 patients
ith a prior history of coronary artery bypass grafting or myocar-
ial infarction were excluded. The first lesion attempted during
ultivessel PCI was assumed to be the culprit. Patients with
issing lesion information (n  767) were excluded. The final
tudy population consisted of 30,386 patients. Clinical outcomes
ithin the ACC-NCDR registry were limited to recorded in-
ospital events without central adjudication. Details of the defini-
ions are available online (6).
Among the 30,386 NSTEMI patients evaluated, the culprit
esion was located in the LAD in 11,609 (38%), RCA in 10,418
34%), and left circumflex (LCX) in 8,359 (28%). A total of 7,199
atients (24%) had an occluded infarct artery at the time of
ngiography. Although patients with an occluded infarct artery
ere younger than patients with a nonoccluded artery (58 years vs.
3 years), with a lower prevalence of comorbidities such as diabetes
22% vs. 28%), hypertension (60% vs. 69%), prior stroke (6% vs.
0%), and peripheral vascular disease (6% vs. 9%, p  0.0001 for
ll), the rates of mortality, post-procedural cardiogenic shock, and
eart failure for the occluded group were higher (Table 1). Overall
rocedural success rates for occluded culprit lesions were lower (p 
.0001) with more frequent procedural complications (p  0.0001).
here were no significant differences in post-procedural renal failure
r vascular or bleeding complications. iThe culprit lesion was identified more frequently in the pos-
erolateral territory among patients with an occluded infarct artery
Coronary Artery Surgery Study segment numbers 3 to 8 and 18 to
7) compared with patients with a nonoccluded artery (40% vs.
2%, p  0.0001). Clinical outcomes were similar between
osterolateral and nonposterolateral culprit groups in both oc-
luded and nonoccluded vessels, with a few exceptions (Table 2).
leeding rates were mildly, but significantly, lower in patients with
osterolateral culprits in both occluded and nonoccluded groups. A
onoccluded posterolateral culprit was associated with the lowest
ortality.
In this study, patients with NSTEMI undergoing PCI were
east likely to present with a LCX culprit lesion, confirming what
as been described in studies of STEMI. This implies that plaque
upture and thrombosis resulting in myocardial necrosis occur less
ften in the LCX compared with the LAD and RCA. Why plaque
upture would be less likely in the circumflex distribution is not
lear. Studies of coronary calcification have not shown differential
paring of the LCX (7). One potential explanation is that the
eometry of the LCX and its branches results in differences in wall
hear stress compared with the LAD and RCA (8,9). Alterna-
ively, depending on anatomic variations in vessel size and surface
rea, as well as total amount of left ventricular mass perfused by the
CX, simple probability may be a determining factor in the
linical Outcomes by Culprit Lesion Patency
Table 1 Clinical Outcomes by Culprit Lesion Patency
Occluded
Culprit
(n  7,199)
Nonoccluded
Culprit
(n  23,187) p Value
Mortality (%) 2.5 1.4 0.0001
Cardiogenic shock (%) 1.6 1.0 0.0001
Congestive heart
failure (%)
1.8 1.3 0.0002
Stroke (%) 0.7 0.6 0.14
Renal failure (%)* 1.0 0.9 0.25
Vascular
complications (%)†
1.1 1.4 0.24
Bleeding
complications (%)‡
3.4 3.7 0.23
he p values are based on Pearson chi-square tests for all categorical row variables and Wilcoxon
ank sum and signed rank tests for all continuous/ordinal row variables. *Renal failure is defined
s serum creatinine increase to 2.0 mg/dl and 2 times the baseline creatinine level or a new
equirement for dialysis. †Vascular complications are defined as any bleeding complication, access
ite occlusion, peripheral embolization, dissection, pseudoaneurysm, or arteriovenous fistula.
Bleeding complications are defined as any percutaneous access site, retroperitoneal, gastroin-
estinal, genitourinary, or other bleeding.ncidence of plaque rupture and thrombosis.
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October 14, 2008:1347–51Approximately one-quarter of patients with NSTEMI had an
ccluded culprit vessel at the time of angiography. Of these, 66%
ccurred in the posterolateral distribution, demonstrating the
imitations of the current diagnostic approach to acute coronary
yndromes, which relies heavily on STEMI/NSTEMI dichotomi-
ation for early treatment decisions. Because patients who were
ound to have an occluded infarct artery suffered worse outcomes,
he need for additional methods to rapidly identify patients with
ccluded arteries despite the absence of ST-segment elevation is
ighlighted. Currently, the use of posterior electrocardiographic leads
V7 to V9) is a Class IIa recommendation in patients presenting with
schemic chest discomfort (10). Other potential diagnostic modalities
nclude emergent transthoracic echocardiography, immediate nuclear
yocardial perfusion imaging, computed tomographic coronary an-
iography, or traditional invasive coronary angiography on a time scale
sually reserved for STEMI patients. These approaches, alone or in
ombination, deserve further investigation.
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linical Outcomes by Culprit Lesion Location
Table 2 Clinical Outcomes by Culprit Lesion Location
Occluded Culprit
Posterolateral
(n  2,856)
Nonposterolatera
(n  4,343)
Mortality (%) 2.3 2.7
Cardiogenic shock (%) 1.3 1.8
Congestive heart failure (%) 1.9 1.7
Stroke (%) 0.8 0.6
Renal failure (%)* 1.0 1.0
Vascular complications (%)† 1.0 1.1
Bleeding complications (%)‡ 2.7 3.8
he p values are based on Pearson chi-square tests for all categorical row variables and Wilcoxon
2.0 mg/dl and2 times the baseline creatinine level or a new requirement for dialysis. †Vascula
issection, pseudoaneurysm, or arteriovenous fistula. ‡Bleeding complications are defined as anyyers Squibb, Sanofi-Aventis/Bristol-Myers Squibb Partnership, Bristol-Myers
quibb/Merck Partnership, and Schering-Plough. Dr. Roe has received research
rants to institution from Bristol-Myers Squibb, Sanofi-Aventis, Schering-Plough,
AI Pharmaceuticals, Portola Pharmaceuticals, Lilly, and Daiichi-Sankyo.
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Nonoccluded Culprit
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Posterolateral
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0.76 1.4 1.3 0.76
0.19 0.6 0.7 0.01
0.94 0.7 0.9 0.09
0.75 1.4 1.4 0.35
0.02 3.3 4.0 0.005
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